- Obama takes aim at ‘corporate deserters’
- Dick’s Sporting Goods lays off 478 PGA golf pros
- Senators: Cease-fire must allow Israel to defend against rockets, tunnels
- Sierra Leone doctor fighting Ebola catches disease
- Iraq welcomes Russian fighter jets, helicopter gunships into ISIL fight
- John McCain laments: Obama’s ‘self-pity … is really kind of sad’
- GOP offer to fix VA gives $10 billion in emergency funds
- Paul Ryan offers to repair U.S. economic safety net with a single grant stream
- Kim Jong-un builds bond with Putin: $250M Russia-backed addition to key port opens
- Pope Francis meets Meriam Ibrahim, a Sudanese woman sentenced to death
Court battle looms over drug act on data mining
Question of the Day
Ed Shanbacker, executive vice president of the Medical Society of the District of Columbia, said the group remains opposed to the overall bill and is concerned that it could prompt pharmaceutical companies to take their business elsewhere.
“This bill is a case of the government in search of a problem,” Mr. Shanbacker said. “If the District is a hard place to do business, the drug companies will downplay their presence here.”
The medical society’s concerns were partly mollified when the council amended the bill’s provision on regulating off-label use of drugs. The bill now requires doctors only to explain a drug’s potential side effects to patients, rather than requiring doctors to obtain written informed consent from them.
The bill’s intent to curb pharmaceutical companies from reviewing doctors’ prescriptions without their knowledge and targeting them with aggressive marketing is a national issue.
Two recent federal court decisions on similar laws in New Hampshire and Maine suggest that the legislation, if passed, will end up in court. In April, a federal judge in New Hampshire overturned a state law that restricted access by medical data companies to a doctor’s prescribing information. Last month, a federal judge in Maine prevented a similar law from taking effect, saying it would violate the free speech guarantee of the First Amendment.
Mr. Catania said he is not sure how the bill will be constructed in light of the recent court decisions, but added, “I’m not afraid of litigation. The fact that this mighty industry can tie up government in court does not mean governments stop working.”
Mr. Frankel insisted that health care information should be transparent in order to improve quality and keep costs down. He pointed to the District’s high rate of HIV/AIDS patients as a specific reason to allow the exchange of prescribing information between doctors and drug companies.
“The bill is the wrong prescription for public health, especially for a city dealing with public health crises like the HIV/AIDS epidemic. Now that the city has a clearer picture of the affected population, why would they draw the blinds on how that population is being treated? That is one of the many points we are making to City Council members,” he said.
• Jim McElhatton contributed to this article.
Second- and third-stringers eye 2016 if front-runner stumbles
- 'We're coming for you, Barack Obama': Top U.S. official discloses threat from ISIL terrorists
- Obama orders Pentagon advisers to Ukraine
- NAPOLITANO: What if our democracy is a fraud?
- Hamas rejects Kerry's call for cease-fire; Fears grow others could join fight against Israel
- State Department indicates Nouri al-Maliki's days numbered as Iraq prime minister
- Inside China: Massive flight woes and a missile test
- Algerian plane diverted due to storms, second aircraft: 116 missing
- Evidence shows Russia firing artillery into Ukraine: Pentagon
- Obama family set to buy $4.25M desert home in California: report
- Norway expects imminent 'concrete threat' from ISIL terrorists 'within days'
Obama's biggest White House 'fails'
Celebrities turned politicians
Athletes turned actors
20 gadgets that changed the world
Fighting in Iraq